News

• Investor Relations

Financial Results Presentation Script, Q4-FY2024

• Investor Relations

Notice Regarding Unauthorized Access to Our Servers

• Investor Relations

Convocation Notice of The 113th Ordinary General Meeting of Shareholders

• Investor Relations

Financial Results Presentation Material, Q4-FY2024

• Investor Relations

Notice Regarding Partial Amendment and Continuation of Performance-linked Stock Compensation Plan

• Investor Relations

Notice Regarding Dividend of Surplus

• Investor Relations

Consolidated Financial Results, Q4-FY2024

• Investor Relations

Mid-Term Management Plan 2027, Presentation Script

• Research and Development

Nippon Shokubai to Exhibit at “TIDES USA 2025”

• Investor Relations

Mid-Term Management Plan 2027

Nippon Shokubai Signs Location Agreement for Establishment of New IONEL™ Plant

• Investor Relations

(Updates to previously disclosed information)Notice of Completion of Acquisition of Shares in Emulsion Technology Co., Ltd.(to Make It a Subsidiary)

• Investor Relations

Notice Regarding Completion of Payment for Treasury Stock as Granting of Shares Through Employee Stockholding Association and Partial Forfeiture

Nippon Shokubai to Exhibit at European Coatings Show (ECS) 2025

• Investor Relations

(Updates to previously disclosed information) Notice of Decision to Construct New Plant for LiFSI (IONEL™) used as Electrolyte for Lithium-ion Batteries

• Investor Relations

Financial Results Supplementary Material, Q3-FY2024

• Investor Relations

Consolidated Financial Results, Q3-FY2024

Nippon Shokubai Announces Distribution Agreement with the University of Manchester -Initiated Startup Holiferm

• Investor Relations

Notice Concerning Change of Major Shareholder

• Research and Development

3D Cell Culture Vessel “MicoCell™” First Application in Regenerative Medicine